Sulfur-containing therapeutics in the treatment of Alzheimer's disease

H Zhu, V Dronamraju, W Xie, SS More - Medicinal Chemistry Research, 2021 - Springer
Sulfur is widely existent in natural products and synthetic organic compounds as
organosulfur, which are often associated with a multitude of biological activities …

A critical update on the strategies towards small molecule inhibitors targeting Serine/arginine-rich (SR) proteins and Serine/arginine-rich proteins related kinases in …

J Tang, Y Xie, J Huang, L Zhang, W Jiang, Z Li… - Bioorganic & Medicinal …, 2022 - Elsevier
90% of genes in the human body undergo alternative splicing (AS) after transcription, which
enriches protein species and regulates protein levels. However, there is growing evidence …

[HTML][HTML] A harmine-derived beta-carboline displays anti-cancer effects in vitro by targeting protein synthesis

A Carvalho, J Chu, C Meinguet, R Kiss… - European journal of …, 2017 - Elsevier
Growing evidence indicates that protein synthesis is deregulated in cancer onset and
progression and targeting this process might be a selective way to combat cancers. While …

Novel factors modulating human β‐cell proliferation

J Shirakawa, RN Kulkarni - Diabetes, Obesity and Metabolism, 2016 - Wiley Online Library
β‐Cell dysfunction in type 1 and type 2 diabetes is accompanied by a progressive loss of β‐
cells, and an understanding of the cellular mechanism (s) that regulate β‐cell mass will …

CMGC kinases in health and cancer

I Chowdhury, G Dashi, S Keskitalo - Cancers, 2023 - mdpi.com
Simple Summary CMGC kinases, named after the initials of its main kinase families, C DKs,
M APKs, G SKs, and C LKs, play critical roles in many cellular processes. Dysregulation of …

The biology, pathogenesis and clinical aspects of acute lymphoblastic leukemia in children with Down syndrome

P Lee, R Bhansali, S Izraeli, N Hijiya, JD Crispino - Leukemia, 2016 - nature.com
Children with Down syndrome (DS) are at a 20-fold increased risk for acute lymphoblastic
leukemia (DS-ALL). Although the etiology of this higher risk of developing leukemia remains …

Structural optimization and pharmacological evaluation of inhibitors targeting dual-specificity tyrosine phosphorylation-regulated kinases (DYRK) and CDC-like …

Q Zhou, AF Phoa, RH Abbassi, M Hoque… - Journal of Medicinal …, 2017 - ACS Publications
The DYRK family contains kinases that are up-regulated in malignancy and control several
cancer hallmarks. To assess the anticancer potential of inhibitors targeting DYRK kinases …

New pyrido [3, 4-g] quinazoline derivatives as CLK1 and DYRK1A inhibitors: synthesis, biological evaluation and binding mode analysis

H Tazarki, W Zeinyeh, YJ Esvan, S Knapp… - European Journal of …, 2019 - Elsevier
Abstract Cdc2-like kinase 1 (CLK1) and dual specificity tyrosine phosphorylation-regulated
kinase 1A (DYRK1A) are involved in the regulation of alternative pre-mRNA splicing …

Dual‐specificity tyrosine phosphorylation–regulated kinase 3 loss activates purine metabolism and promotes hepatocellular carcinoma progression

F Ma, Y Zhu, X Liu, Q Zhou, X Hong, C Qu, X Feng… - Hepatology, 2019 - journals.lww.com
Cancer cells metabolize different energy sources to generate biomass rapidly. The purine
biosynthetic pathway was recently identified as an important source of metabolic …

Structure–Activity Relationship in the Leucettine Family of Kinase Inhibitors

T Tahtouh, E Durieu, B Villiers, C Bruyère… - Journal of medicinal …, 2021 - ACS Publications
The protein kinase DYRK1A is involved in Alzheimer's disease, Down syndrome, diabetes,
viral infections, and leukemia. Leucettines, a family of 2-aminoimidazolin-4-ones derived …